Bourgeon Capital Management LLC Crispr Therapeutics Ag Transaction History

Bourgeon Capital Management LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Jan 30, 2024	BUY	$38.62 - $72.18 $19,310 - $36,090	500 Added 1000.0%	550 $34,000
Q2 2023 Jul 20, 2023	SELL	$43.47 - $67.77 $86,940 - $135,540	-2,000 Reduced 97.56%	50 $2,000
Q1 2023 Apr 17, 2023	BUY	$41.0 - $56.12 $63,550 - $86,986	1,550 Added 310.0%	2,050 $92,000
Q2 2022 Jul 27, 2022	SELL	$43.23 - $73.83 $56,198 - $95,979	-1,300 Reduced 72.22%	500 $30,000
Q1 2022 May 03, 2022	BUY	$53.19 - $79.24 $39,892 - $59,429	750 Added 71.43%	1,800 $113,000
Q4 2021 Jan 31, 2022	BUY	$70.09 - $111.29 $35,045 - $55,645	500 Added 90.91%	1,050 $80,000
Q3 2021 Nov 09, 2021	BUY	$110.2 - $156.64 $60,610 - $86,151	550 New	550 $62,000
Q1 2021 May 13, 2021	SELL	$110.72 - $210.04 $11,072 - $21,004	-100 Closed	0 $0
Q4 2020 Jan 29, 2021	BUY	$79.67 - $173.23 $7,967 - $17,323	100 New	100 $15,000

489

57.9M

1.1M

1.9M

Ticker CRSP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,009,296
Market Cap $3.1B
Description
CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/Cas9 is a gene editing technology that allows for precise directed changes to genomic DNA....

Get notified when there are updates to the investment portfolio of Bourgeon Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Bourgeon Capital Management LLC with notifications on news.